New markers in preeclampsia
- 1 November 2010
- journal article
- review article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 411 (21-22) , 1591-1595
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- VEGF Inhibition and Renal Thrombotic MicroangiopathyNew England Journal of Medicine, 2008
- Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational ageThe Journal of Maternal-Fetal & Neonatal Medicine, 2008
- Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinomaThe Lancet Oncology, 2007
- Soluble fms-Like Tyrosine Kinase 1 Is Increased in Preeclampsia But Not in Normotensive Pregnancies with Small-for-Gestational-Age Neonates: Relationship to Circulating Placental Growth FactorThe Journal of Clinical Endocrinology & Metabolism, 2005
- Pre-eclampsiaThe Lancet, 2005
- Maternal Serum sFlt1 Concentration Is an Early and Reliable Predictive Marker of PreeclampsiaClinical Chemistry, 2004
- Circulating Angiogenic Factors and the Risk of PreeclampsiaNew England Journal of Medicine, 2004
- First Trimester Placental Growth Factor and Soluble Fms-Like Tyrosine Kinase 1 and Risk for PreeclampsiaThe Journal of Clinical Endocrinology & Metabolism, 2004
- Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsiaJournal of Clinical Investigation, 2003
- A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre‐eclamptic pregnanciesBJOG: An International Journal of Obstetrics & Gynaecology, 1994